Inventor · disambiguated record
Paul Yazaki
Also filed as: YAZAKI PAUL · YAZAKI PAUL J
7 granted patents·5 pending applications·40 citations·filing 2005–2024
81Inventor score
Files withHOPE CITY12
Top patents by PatentIndex Score
12 records- 0193US7776330B2Humanized anti-CEA T84.66 antibody and uses thereofHOPE CITY·Filed 2007·Granted Aug 17, 2010·25 cites·9 claims
- 0287US7273608B2Humanized anti-CEA T84.66 antibody and uses thereofHOPE CITY·Filed 2005·Granted Sep 25, 2007·10 cites·6 claims
- 0384US10758632B2NIR-conjugated tumor-specific antibodies and uses thereofHOPE CITY·Filed 2018·Granted Sep 1, 2020·3 cites·14 claims
- 0476US12178887B2NIR-conjugated tumor-specific antibodies and uses thereofHOPE CITY·Filed 2023·Granted Dec 31, 2024·0 cites·6 claims
- 0575US12281152B2TAG72 targeted chimeric antigen receptor modified T cells for treatment of TAG72-positive tumorsHOPE CITY·Filed 2019·Granted Apr 22, 2025·1 cites·42 claims
- 0670US10479826B2Single chain antibody domains for detection of anti-botulinum neurotoxin domains and methods of their useHOPE CITY·Filed 2016·Granted Nov 19, 2019·1 cites·18 claims
- 0764US2025074982A1Bispecific antibodies and uses thereofHOPE CITY·Filed 2024·Application pending·0 cites
- 0857US2020368372A1Nir-conjugated tumor-specific antibodies and uses thereofHOPE CITY·Filed 2020·Application pending·0 cites
- 0956US2023256122A1Combination therapy for treating cancerHOPE CITY·Filed 2022·Application pending·0 cites
- 1054US2023190799A1Chimeric antigen receptor t cells targeting cea and anti-cea-il2 immunocytokines for cancer therapyHOPE CITY·Filed 2022·Application pending·0 cites
- 1146US11666672B2Anti-CD33 antibody-guided imaging and treatment of acute myeloid leukemiaHOPE CITY·Filed 2019·Granted Jun 6, 2023·0 cites·20 claims
- 1246US2022280568A1Dual bispecific antibody compounds and uses thereofHOPE CITY·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Paul Yazaki files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →